SHE:002275 Revenue

In the year 2025, Guilin Sanjin Pharmaceutical had annual revenue of 2.05B CNY, down -6.76%. Guilin Sanjin Pharmaceutical had revenue of 583.35M in the quarter ending December 31, 2025, a decrease of -5.79%.

Revenue

2.05B

Revenue Growth

-6.76%

P/S Ratio

4.09

Revenue / Employee

796.93K

Employees

2,567

Market Cap

8.36B

Revenue Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	2.05B	-148.26M	-6.76%
Dec 31, 2024	2.19B	22.39M	1.03%
Dec 31, 2023	2.17B	211.87M	10.81%
Jan 1, 2023	1.96B	218.51M	12.55%
Jan 1, 2022	1.74B	174.74M	11.15%
Dec 31, 2020	Pro	Pro	Pro
Dec 31, 2019	Pro	Pro	Pro
Dec 31, 2018	Pro	Pro	Pro
Dec 31, 2017	Pro	Pro	Pro
Dec 31, 2016	Pro	Pro	Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name	Revenue
Sichuan Huiyu Pharmaceutical	1.03B
Tianjin Ringpu Bio-Technology	3.40B
Jiuzhitang	2.23B
Jiangsu Kanion Pharmaceutical	3.29B
Hunan Er-Kang Pharmaceutical	1.06B
Shenzhen Neptunus Bioengineering	27.28B
HARBIN GLORIA PHARMACEUTICALS Co., LTD	2.14B
Shandong Lukang Pharmaceutical	5.71B

Revenue Rankings